Company Profile
Memphasys develops, manufactures, and sells cell and protein separation devices, and related consumables for the healthcare, veterinary, and biotechnology market sectors in Australia.
The company offers Felix system, a device separates sperm from raw semen by electrophoresis process and size exclusion membranes, as well as RoXsta, a rapid in vitro antioxidant assessment AI-Port, an ambient temperature semen transport device for artificial insemination in animals.
Additionally, it develops ambient temperature storage product for human sperm; and a medium for human sperm isolation, fertilisation and cryopreservation. Memphasys Limited was incorporated in 2006 and is based in Homebush, Australia.